GSE48812 8 V 1 SULFORAPHANE HUMAN DN (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE48812 8 V 1 SULFORAPHANE HUMAN DN.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE48812 8 V 1 SULFORAPHANE HUMAN DN.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE48812 8 V 1 SULFORAPHANE HUMAN DN.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE48812 8 V 1 SULFORAPHANE HUMAN DN.

Results found

Linked to

 

Label

Description

 

Gene

G protein signaling modulator 3

Gene

ribosomal protein SA 2

Gene

armadillo like helical domain containing 3

Gene

tandem C2 domains, nuclear

Gene

zinc finger protein 501

Gene

Rho GTPase activating protein 40

Gene

solute carrier family 6 member 9

Gene

component of oligomeric golgi complex 4

Gene

FKBP prolyl isomerase family member 15

Gene

G protein-coupled receptor 87

  • Gene

    G protein signaling modulator 3


  • Gene

    ribosomal protein SA 2


  • Gene

    armadillo like helical domain containing 3


  • Gene

    tandem C2 domains, nuclear


  • Gene

    zinc finger protein 501


  • Gene

    Rho GTPase activating protein 40


  • Gene

    solute carrier family 6 member 9


  • Gene

    component of oligomeric golgi complex 4


  • Gene

    FKBP prolyl isomerase family member 15


  • Gene

    G protein-coupled receptor 87

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.